Chemoresistance is a trait of triple-negative breast cancer, but inhibiting LOX by miR-142-3p reduces collagen cross-linking and fibronectin assembly, increases drug penetration and causes the induction of apoptosis and re-sensitisation to chemotherapy [53]. Here, LOX is linked to triple-negative breast carcinoma.